Clarelux

Clobetasol propionate, the active ingredient in Clarelux, is a corticosteroid presented as a 500 microgram/g foam for topical use. It is used in the treatment of skin conditions such as psoriasis in adults and adolescents aged 12 years and older. GNH USA supplies Clarelux as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Clarelux is a potent topical corticosteroid indicated for short-term treatment of scalp conditions that are responsive to steroids but do not respond well to less potent steroids.

Clarelux is a potent topical corticosteroid used to manage inflammatory skin conditions. It is primarily indicated for the treatment of scalp conditions such as psoriasis. The following are the key uses of Clarelux:

- Psoriasis: Effective in reducing inflammation and scaling associated with psoriasis of the scalp. - Eczema: Helps in managing severe cases of eczema that are unresponsive to milder treatments. - Dermatitis: Used to alleviate symptoms of severe dermatitis, including redness and itching. - Lichen Planus: Can be used to treat lichen planus, a condition characterized by inflammatory skin lesions.

Clarelux, like other potent corticosteroids, can cause a range of side effects. Common side effects typically resolve with continued use or after discontinuation of the medication. Serious or rare side effects are less common but require immediate medical attention.

Common Side Effects: - Skin irritation or burning at the application site. - Dryness or peeling of the skin. - Itching or redness. - Acne or folliculitis. - Hyperpigmentation or hypopigmentation. - Allergic contact dermatitis.

Serious or Rare Side Effects: - Skin atrophy or thinning of the skin. - Striae (stretch marks). - Systemic absorption leading to adrenal suppression. - Cushing's syndrome with prolonged use. - Glaucoma or cataracts with ocular exposure. - Secondary infections due to immunosuppression.

Clarelux should be used with caution and under medical supervision. The following precautions should be observed to ensure safe and effective use:

- Avoid prolonged use: Prolonged use can lead to systemic absorption and serious side effects. - Avoid sensitive areas: Do not apply to the face, groin, or axillae unless directed by a healthcare professional. - Monitor for infections: Use with caution in areas with existing infections. - Pregnancy and breastfeeding: Use only if clearly needed and under medical supervision. - Children: Not recommended for use in children under 12 years of age. - Store below 25°C: Keep in the original pack, protect from moisture.

Clarelux can interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. Major interactions should be avoided, while moderate interactions require close monitoring.

Major Interactions (Avoid): - Other topical corticosteroids: Concurrent use can increase the risk of systemic side effects. - Immunosuppressants: Increased risk of immunosuppression and infections. - Systemic corticosteroids: Increased risk of adrenal suppression and Cushing's syndrome.

Moderate Interactions (Monitor Closely): - Anticoagulants: May increase the risk of bleeding. - Antidiabetics: May affect blood glucose levels. - Antihypertensives: May alter blood pressure control.